Free Trial

This company has been marked as potentially delisted and may not be actively trading.

GeoVax Labs (GOVXW) Competitors

GeoVax Labs logo

GOVXW vs. AIMDW, ALVOW, ARAV, ACABW, and RNA

Should you be buying GeoVax Labs stock or one of its competitors? The main competitors of GeoVax Labs include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Avidity Biosciences (RNA). These companies are all part of the "pharmaceutical products" industry.

How does GeoVax Labs compare to Ainos?

GeoVax Labs (NASDAQ:GOVXW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeoVax Labs$6.14MN/AN/AN/AN/A
Ainos$124.16KN/AN/AN/AN/A

In the previous week, Ainos' average media sentiment score of 0.00 beat GeoVax Labs' score of -0.48 indicating that Ainos is being referred to more favorably in the news media.

Company Overall Sentiment
GeoVax Labs Neutral
Ainos Neutral

Company Net Margins Return on Equity Return on Assets
GeoVax LabsN/A N/A N/A
Ainos N/A N/A N/A

Summary

GeoVax Labs and Ainos tied by winning 1 of the 2 factors compared between the two stocks.

How does GeoVax Labs compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and GeoVax Labs (NASDAQ:GOVXW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$586.32MN/AN/AN/AN/A
GeoVax Labs$6.14MN/AN/AN/AN/A

In the previous week, Alvotech's average media sentiment score of 0.00 beat GeoVax Labs' score of -0.48 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Neutral
GeoVax Labs Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
GeoVax Labs N/A N/A N/A

Summary

Alvotech beats GeoVax Labs on 2 of the 2 factors compared between the two stocks.

How does GeoVax Labs compare to Aravive?

Aravive (NASDAQ:ARAV) and GeoVax Labs (NASDAQ:GOVXW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, valuation, dividends and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AraviveN/AN/AN/A-$0.90N/A
GeoVax Labs$6.14MN/AN/AN/AN/A

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Aravive's average media sentiment score of 0.00 beat GeoVax Labs' score of -0.48 indicating that Aravive is being referred to more favorably in the media.

Company Overall Sentiment
Aravive Neutral
GeoVax Labs Neutral

Company Net Margins Return on Equity Return on Assets
AraviveN/A N/A N/A
GeoVax Labs N/A N/A N/A

Summary

Aravive beats GeoVax Labs on 3 of the 4 factors compared between the two stocks.

How does GeoVax Labs compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and GeoVax Labs (NASDAQ:GOVXW) are both pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 beat GeoVax Labs' score of -0.48 indicating that Atlantic Coastal Acquisition Corp. II is being referred to more favorably in the media.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
GeoVax Labs Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
GeoVax Labs N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
GeoVax Labs$6.14MN/AN/AN/AN/A

Summary

Atlantic Coastal Acquisition Corp. II and GeoVax Labs tied by winning 1 of the 2 factors compared between the two stocks.

How does GeoVax Labs compare to Avidity Biosciences?

GeoVax Labs (NASDAQ:GOVXW) and Avidity Biosciences (NASDAQ:RNA) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Avidity Biosciences has a consensus target price of $69.42, indicating a potential upside of 437.73%. Given Avidity Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Avidity Biosciences is more favorable than GeoVax Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GeoVax Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Avidity Biosciences
1 Sell rating(s)
12 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.32

In the previous week, Avidity Biosciences had 1 more articles in the media than GeoVax Labs. MarketBeat recorded 1 mentions for Avidity Biosciences and 0 mentions for GeoVax Labs. Avidity Biosciences' average media sentiment score of 0.00 beat GeoVax Labs' score of -0.48 indicating that Avidity Biosciences is being referred to more favorably in the news media.

Company Overall Sentiment
GeoVax Labs Neutral
Avidity Biosciences Neutral

GeoVax Labs has a net margin of 0.00% compared to Avidity Biosciences' net margin of -3,650.39%. GeoVax Labs' return on equity of 0.00% beat Avidity Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
GeoVax LabsN/A N/A N/A
Avidity Biosciences -3,650.39%-44.92%-39.57%

GeoVax Labs has higher earnings, but lower revenue than Avidity Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GeoVax Labs$6.14MN/AN/AN/AN/A
Avidity Biosciences$18.62MN/A-$322.30MN/AN/A

Summary

Avidity Biosciences beats GeoVax Labs on 7 of the 10 factors compared between the two stocks.

Get GeoVax Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for GOVXW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GOVXW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GOVXW vs. The Competition

MetricGeoVax LabsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$451.91M$6.25B$11.77B
Dividend YieldN/A3.86%2.74%5.26%
P/E RatioN/A4.1429.2527.07
Price / SalesN/A6,879.71504.6873.47
Price / CashN/A13.1343.3053.90
Price / BookN/A77.749.676.69
Net IncomeN/A-$96.07M$3.55B$332.64M

GeoVax Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GOVXW
GeoVax Labs
N/A$0.00
flat
N/AN/A$0.00$6.14MN/A10
AIMDW
Ainos
N/A$0.11
flat
N/AN/A$0.00$124.16KN/A40
ALVOW
Alvotech
N/A$0.21
-18.2%
N/AN/A$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat
N/AN/A$0.00N/AN/A15

Related Companies and Tools


This page (NASDAQ:GOVXW) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners